These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
80 related items for PubMed ID: 1626165
1. [Clinical usefulness of the glucagon test in the study of pancreatic islet cell function]. Llorente I, Goñi MJ, Forga L, Monreal M, Lizcano F, Moncada E. Rev Med Univ Navarra; 1992; 37(1):25-9. PubMed ID: 1626165 [Abstract] [Full Text] [Related]
2. [Evaluation of beta cell function in non-insulin-dependent diabetes mellitus (NIDDM) and its correlations with clinico-metabolic parameters]. Santoro E, Gianni R, Maggi L, Tomassini CR, Bisacchi U. G Clin Med; 1989 Feb; 70(2):95-9. PubMed ID: 2666224 [Abstract] [Full Text] [Related]
3. [Clinical significance of measuring serum c-peptide before and after glucagon injection]. Kan Y, Chi Z. Zhonghua Yi Xue Za Zhi; 1991 Jan; 71(1):16-7, 4. PubMed ID: 1850647 [Abstract] [Full Text] [Related]
4. The role of diminished beta cell reserve and insulin resistance in secondary sulfonylurea failure of type 2 diabetes mellitus. Rattarasarn C, Thamprasit A, Leelawattana R, Soonthornpun S, Setasuban W. J Med Assoc Thai; 2001 Dec; 84(12):1754-62. PubMed ID: 11999824 [Abstract] [Full Text] [Related]
5. T-cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe beta-cell lesions in phenotypic type 2 diabetes. Goel A, Chiu H, Felton J, Palmer JP, Brooks-Worrell B. Diabetes; 2007 Aug; 56(8):2110-5. PubMed ID: 17473222 [Abstract] [Full Text] [Related]
6. [Islet beta-cell function in failures following sulfonylurea therapy in diabetics, by determination of serum C-peptide]. Costamaillere L, Arteaga A, Velasco N, Pellegrino MR, Foradori A, López G, Acosta AM. Rev Med Chil; 1984 Dec; 112(12):1206-13. PubMed ID: 6399604 [No Abstract] [Full Text] [Related]
12. C-peptide response to glucagon in diabetics with and without complications. Smith RB, Pyke DA, Watkins PJ, Binder C, Faber OK. N Z Med J; 1979 Apr 25; 89(634):304-6. PubMed ID: 377156 [Abstract] [Full Text] [Related]
15. The C-peptide response to glucagon injections in IDDM and NIDDM patients. Poulsen S, Billesbølle P, Kølendorf K, Thorsteinsson B. Horm Metab Res; 1985 Jan 25; 17(1):39-40. PubMed ID: 3967844 [No Abstract] [Full Text] [Related]
16. Insulin/C-peptide response to intravenous glucagon. A dose-response study in normal and non-insulin-dependent diabetic subjects. Snorgaard O, Hasselstrøm K, Lumholtz IB, Thorsteinsson B, Siersbaek-Nielsen K. Acta Endocrinol (Copenh); 1988 Jan 25; 117(1):109-15. PubMed ID: 3289292 [Abstract] [Full Text] [Related]
19. Basal and postglucagon C-peptide levels in Ethiopians with diabetes. Siraj ES, Reddy SS, Scherbaum WA, Abdulkadir J, Hammel JP, Faiman C. Diabetes Care; 2002 Mar 25; 25(3):453-7. PubMed ID: 11874929 [Abstract] [Full Text] [Related]
20. Utility of glucagon stimulation test in type 1 diabetes after pancreas transplantation. Hiratsuka I, Suzuki A, Kondo-Ando M, Hirai H, Maeda Y, Sekiguchi-Ueda S, Shibata M, Takayanagi T, Makino M, Fukami N, Itoh T, Sasaki H, Kusaka M, Kenmochi T, Hoshinaga K, Itoh M. Transplant Proc; 2014 Apr 25; 46(3):967-9. PubMed ID: 24767392 [Abstract] [Full Text] [Related] Page: [Next] [New Search]